Goncalves Joana's Form 4 filing
Oruka Therapeutics, Inc. (ORKA) · filed Mar 17, 2026
- Accession no.
- 0000907654-26-000030
- Filed
- Mar 17, 2026
- Trade date
- Mar 16, 2026
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions and 2 derivative transactions. Open-market sales total $312.6K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Goncalves JoanaCIK 0001756991 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 16, 2026 | Common Stock | MOption exerciseAcquired | +3,500 | $6.84 | +$23,940 | 37,518 | Direct | |
| Mar 16, 2026 | Common Stock | MOption exerciseAcquired | +3,500 | $7.80 | +$27,300 | 41,018 | Direct | |
| Mar 16, 2026 | Common Stock | SSaleDisposed | −2,921 | $40.11 | −$117,161.31 | 38,097 | Direct | |
| Mar 16, 2026 | Common Stock | SSaleDisposed | −2,902 | $41.20 | −$119,562.4 | 35,195 | Direct | |
| Mar 16, 2026 | Common Stock | SSaleDisposed | −1,177 | $41.94 | −$49,363.38 | 34,018 | Direct | |
| Mar 16, 2026 | Common Stock | SSaleDisposed | −641 | $41.30 | −$26,473.3 | 33,377 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 16, 2026 | Common Stock | MOption exerciseDisposed | −3,500 | $0.00 | $0 | 214,563 | Direct | |
| Mar 16, 2026 | Common Stock | MOption exerciseDisposed | −3,500 | $0.00 | $0 | 185,992 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.